Member Info for JohnHenry

Latino i suggest you read the RNS, The loan and £2.5M subscription will only give them enough funding for 2 months, where further funding will be needed. Existing shareholder will be wiped out.

Todays move up was shorts closing. Back to around 1.7p over the next few weeks.

Equity investor is about to purchase 80% of the company for £2.5M @ a purchase price of 1.7p Massive dilution for existing shareholders.

Calm your farm, AVA6000 will be taken forward either with Avacta in control or a large pharma. i would suggest a large Pharma would bring AVA6000 to market a lot quicker than Avacta.The tech will just be transferred to a company with far deeper pockets and more likely find its way into hospitals a dam sight quicker.

Icecool without news SP will simply drift lower throughout the summer low volume lull. Aimho

Bline59 an SP of £1.85p was massively overvalued.

Cohort 6 is at least 6-8 weeks away if on the same timelines as cohort5 . What SP by then as there is simply no drivers on the horizon. 60p ? SP is in decline until an inflection point.

Investor base is pretty much all retail, it will be their decision.

At this stage for the Therapeutics division i do.

Hostile bid around 250-300p may succeed.

16p bid brought out 400k of sellers, imho small pullback before 17-18p and consolidation.

@ the 21 EMA

Chart show minor resistance around 17p

Also find on Youtube

Maybe not the convertibles issued to directors but third parties ??

Overhang from convertibles cleared ?

Quite a few trades going through at Mid im guessing they are sells as im getting quote above mid to buy.

Im expecting a retest of 95p before a recovery can be made. Market needs to clear the weak hands.

Imho sellers not entirely cleared.

Imho the convertible note selling is pretty much done. Bottom pretty much in, cheap as chips on fundamentals. I hold average 5.7p

Different protocol, Webinar is operated by IMC previous webinars have been run by the company.

Dont try and infer circumstances that are there. Filtered.